Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig A Beam

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Diabetes Care|June 16, 2012
Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youthKendra Vehik, David Cuthbertson, David Boulware, et al.
Scientific Reports|January 22, 2020
Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology AnalysisCraig A Beam, Clive Wasserfall, Alyssa Woodwyk, et al.
The Journal of Clinical Investigation|February 3, 2015
β cell death and dysfunction during type 1 diabetes development in at-risk individualsKevan C Herold, Sahar Usmani-Brown, Tara Ghazi, et al.
Diabetes|July 19, 2013
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participantsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Cancer Research|November 25, 2003
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line modelLori A Hazlehurst, Steven A Enkemann, Craig A Beam, et al.
Diabetes Care|July 3, 2013
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsJay M Sosenko, Jay S Skyler, Jerry P Palmer, et al.
Diabetes Care|June 18, 2011
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|February 25, 2018
Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787Jay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|May 2, 2012
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|March 12, 2015
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 monthsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Diabetes Care|June 16, 2012
Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youthKendra Vehik, David Cuthbertson, David Boulware, et al.
Scientific Reports|January 22, 2020
Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology AnalysisCraig A Beam, Clive Wasserfall, Alyssa Woodwyk, et al.
The Journal of Clinical Investigation|February 3, 2015
β cell death and dysfunction during type 1 diabetes development in at-risk individualsKevan C Herold, Sahar Usmani-Brown, Tara Ghazi, et al.
Diabetes|July 19, 2013
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participantsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Cancer Research|November 25, 2003
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line modelLori A Hazlehurst, Steven A Enkemann, Craig A Beam, et al.
Diabetes Care|July 3, 2013
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsJay M Sosenko, Jay S Skyler, Jerry P Palmer, et al.
Diabetes Care|June 18, 2011
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|February 25, 2018
Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787Jay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|May 2, 2012
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|March 12, 2015
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 monthsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
Pageof 5